Selskabets formål er direkte eller indirekte gennem datter- eller associerede virksomheder og såvel i indland som udland at drive virksomhed med (i) generel handel og industri, herunder finansiering, (ii) produktion, salg og udvikling af vitamin- og mineralblandinger og desinfektionsmidler til landbrug og industri, (iii) salg og udvikling af midler til bekæmpelse og forebyggelse af veterinære sygdomme, og (iv) øvrig virksomhed som efter bestyrelsens skøn står i forbindelse med litra (i)-(iii).
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 1 mia. | 154.1 mio. | 3.1 mia. | 978.5 mio. | 124 | |
CVR: 82776214
Secondary names: VILOGROUP A/S, DLG INGREDIENTS A/S, AAA FARMERS A/S
54 properties
Upgrade to Pro to see addresses, building data and ownership details
Morten Riber Pryds joined the board
Christina Nielsen left the board
Bøje Schaumann Kjær joined as ADM. DIR.
Dennis Jørgensen left as ADM. DIR.
Companies in the same industry and area
Compared to 42 companies in Fremstilling af færdige foderblandinger til landbrugsdyr
Comparison is based on industry median values
VILOFOSS A/S demonstrates a solid financial health with a consistent profitability trend, reporting a profit of 154.1 million DKK in 2024, slightly up from 153.5 million DKK in 2023. However, revenue has declined from 1.38 billion DKK in 2022 to 1.05 billion DKK in 2024, indicating a downward trajectory in sales. The company's equity has significantly increased to 978.5 million DKK, reflecting a strong capital position, although the declining revenue trend raises concerns about market competitiveness. With a robust equity base and stable profit margins, VILOFOSS A/S remains a key player in the agricultural feed manufacturing industry, though it must address revenue challenges to sustain its position.
AI-generated summary